<code id='5153335EC4'></code><style id='5153335EC4'></style>
    • <acronym id='5153335EC4'></acronym>
      <center id='5153335EC4'><center id='5153335EC4'><tfoot id='5153335EC4'></tfoot></center><abbr id='5153335EC4'><dir id='5153335EC4'><tfoot id='5153335EC4'></tfoot><noframes id='5153335EC4'>

    • <optgroup id='5153335EC4'><strike id='5153335EC4'><sup id='5153335EC4'></sup></strike><code id='5153335EC4'></code></optgroup>
        1. <b id='5153335EC4'><label id='5153335EC4'><select id='5153335EC4'><dt id='5153335EC4'><span id='5153335EC4'></span></dt></select></label></b><u id='5153335EC4'></u>
          <i id='5153335EC4'><strike id='5153335EC4'><tt id='5153335EC4'><pre id='5153335EC4'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:629
          Cosmetics
          Alberto Pellaschiar/AP

          WASHINGTON — For those already felled by fumes from the Brazilian Blowout, it might be small consolation, but lawmakers are pushing ahead with a campaign for better oversight of the beauty business.

          Despite its booming growth, the cosmetics industry in the US has been virtually unregulated. The Food, Drug, and Cosmetic Act, adopted in 1938, essentially allowed personal care product companies to self-police.

          advertisement

          But rising public concern over bad reactions to makeup, hair dyes, and fragrances, as well as evidence of long-term health risks from some of their chemical contents, has led lawmakers to try to toughen the regulatory framework for the $60 billion enhancement industry.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs
          Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

          YichuanCao/SipaUSAviaAPImagesGileadSciencessaidMondaythatTrodelvy,its“smart-bomb”medicinethatcombine

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          White House pharmacy plagued with problems, investigation finds

          SamuelCorum/GettyImagesThere’sapharmacyintheWhiteHouse—or,atleast,there’sasignthatsays“Pharmacy,”tho